Allarity Therapeutics, Inc. announced a private placement of a senior convertible promissory note at a principal amount of $660,000 issued at a discount of 10% for the gross proceeds of $600,000 on March 14, 2024. The note will have a coupon rate of 8% and will be convertible into common shares of the company at a conversion price of $0.3501 per share. The notes will be matured on March 14, 2025.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.796 USD | +0.62% | -11.65% | -92.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-92.78% | 246K | |
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.88% | 21.93B | |
-6.17% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. announced that it has received $0.6 million in funding